NASDAQ: SCTX
Scribe Therapeutics Inc Stock Ownership - Who owns Scribe Therapeutics?

Insider buying vs selling

Have Scribe Therapeutics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when SCTX insiders and whales buy or sell their stock.

SCTX Shareholders

What type of owners hold Scribe Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Lilly Co Eli6.52%1,054,828$22.84MInsider
Behzad Aghazadeh4.31%697,650$15.10MInsider
Jennifer A. Doudna3.65%591,036$12.80MInsider
Brett Staahl3.24%524,336$11.35MInsider
Benjamin L. Oakes3.13%506,602$10.97MInsider
Svetlana Lucas0.19%30,695$664.55kInsider

1 of 1

SCTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABVC3.14%80.87%
ACET28.27%71.73%Net Buying
ABVX63.37%0.00%
ADMA79.02%20.98%Net SellingNet Buying
AARD46.75%46.87%Net Buying

Scribe Therapeutics Stock Ownership FAQ

Who owns Scribe Therapeutics?

Scribe Therapeutics (NASDAQ: SCTX) is owned by 0.00% institutional shareholders, 21.04% Scribe Therapeutics insiders, and 78.96% retail investors. Lilly Co Eli is the largest individual Scribe Therapeutics shareholder, owning 1.05M shares representing 6.52% of the company. Lilly Co Eli's Scribe Therapeutics shares are currently valued at $22.84M.

If you're new to stock investing, here's how to buy Scribe Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.